CrossRef
Open Access
2025
2139P SKB315, a novel claudin 18.2 (CLDN18.2) antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors including gastric/ gastroesophageal junction cancer (GC/GEJC): A phase I study
T. Deng
J. Zhang
X. Yuan
X. Qu
M. Cai
+10 lainnya
Penulis (15)
T
T. Deng
J
J. Zhang
X
X. Yuan
X
X. Qu
M
M. Cai
J
J. Wang
Y
Y. Zhang
Z
Z. Niu
S
S. Ni
L
L. Liu
Y
Y. Li
X
X. Li
X
X. Jin
J
J. Ge
Y
Y. Ba
Format Sitasi
Deng, T., Zhang, J., Yuan, X., Qu, X., Cai, M., Wang, J. et al. (2025). 2139P SKB315, a novel claudin 18.2 (CLDN18.2) antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors including gastric/ gastroesophageal junction cancer (GC/GEJC): A phase I study. https://doi.org/10.1016/j.annonc.2025.08.2758
Akses Cepat
PDF tidak tersedia langsung
Cek di sumber asli →Informasi Jurnal
- Tahun Terbit
- 2025
- Bahasa
- en
- Sumber Database
- CrossRef
- DOI
- 10.1016/j.annonc.2025.08.2758
- Akses
- Open Access ✓